Amsterdam Molecular Therapeutics Holding BV, a Dutch gene therapy company, has set its proposed IPO terms to five million common shares being offered at
Amsterdam Molecular Therapeutics Holding BV, a Dutch gene therapy company, has set its proposed IPO terms to five million common shares being offered at
Copyright PEI Media
Not for publication, email or dissemination
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.